Long-term Safety Study of Treatment With the Thrombopoietin Agonists Eltrombopag and Romiplostim in Patients With Immune Thrombocytopenia (ITP)

NCT01443351 · clinicaltrials.gov ↗

WITHDRAWN

Status

OTHER

Sponsor class

Stopped failure to recruit patients

Conditions

Idiopathic Thrombocytopenic Purpura

Sponsor

Zealand University Hospital

Collaborators

[object Object]
[object Object]